{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:45:16Z","timestamp":1759063516383},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.antiviral.2017.01.024","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:04:23Z","timestamp":1486080263000},"page":"142-150","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62"],"prefix":"10.1016","volume":"140","author":[{"given":"Ryuichi","family":"Majima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Shindoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyofumi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.01.024_bib1","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/JVI.75.8.3859-3872.2001","article-title":"Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9","volume":"75","author":"Ahn","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib2","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1128\/JVI.01002-15","article-title":"Inhibition of O-Linked N-Acetylglucosamine transferase reduces replication of herpes simplex virus and human cytomegalovirus","volume":"89","author":"Angelova","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib3","series-title":"Human Herpesviruses:Biology, Therapy, and Immunoprophylaxis","article-title":"Part III.3 Pathogenesis, clinical disease, host response, and epidemiology: betaherpesviruses","author":"Arvin","year":"2007"},{"key":"10.1016\/j.antiviral.2017.01.024_bib4","series-title":"Human Herpesviruses:Biology, Therapy, and Immunoprophylaxis","article-title":"Part III.2 Pathogenesis, clinical disease, host response, and epidemiology: alphaherpes viruses VZV","author":"Arvin","year":"2007"},{"key":"10.1016\/j.antiviral.2017.01.024_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JVI.79.3.1428-1437.2005","article-title":"The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early protein IE2\/IEP86 affects temporal viral gene expression","volume":"79","author":"Barrasa","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib6","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/JVI.74.16.7230-7237.2000","article-title":"The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P\/CAF","volume":"74","author":"Bryant","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib7","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1099\/0022-1317-74-12-2691","article-title":"The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation","author":"Caswell","year":"1993","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/JVI.80.4.1710-1723.2006","article-title":"Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase","volume":"80","author":"Eisfeld","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/ldt011","article-title":"Recent developments in anti-herpesvirus drugs","volume":"106","author":"Field","year":"2013","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.antiviral.2017.01.024_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-3527(08)60366-8","article-title":"Regulation of human cytomegalovirus gene expression","volume":"54","author":"Fortunato","year":"1999","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2017.01.024_bib11","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.00134-08","article-title":"Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay","volume":"52","author":"Fukui","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.01.024_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/IAI.19.1.199-203.1978","article-title":"Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C","volume":"19","author":"Grose","year":"1978","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2017.01.024_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0042-6822(89)90124-4","article-title":"DNA sequence and comparative analyses of the equine herpesvirus type 1 immediate early gene","volume":"172","author":"Grundy","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2017.01.024_bib14","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/JVI.66.7.4452-4456.1992","article-title":"The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID","volume":"66","author":"Hagemeier","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib15","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1128\/JVI.72.7.5481-5492.1998","article-title":"Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2","volume":"72","author":"Harel","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib16","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/JVI.74.6.2510-2524.2000","article-title":"Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b","volume":"74","author":"Hofmann","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib17","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/AAC.04534-14","article-title":"A\u00a0novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations","volume":"59","author":"Hutterer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.01.024_bib18","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1128\/JVI.01280-12","article-title":"Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein","volume":"86","author":"Inoue","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/JVI.02096-15","article-title":"Functional dharacterization of the serine-rich tract of vricella-zoster virus IE62","volume":"90","author":"Kim","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib20","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/JVI.74.5.2265-2277.2000","article-title":"Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase","volume":"74","author":"Kinchington","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/JVI.66.1.359-366.1992","article-title":"The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles","volume":"66","author":"Kinchington","year":"1992","journal-title":"J.\u00a0Virol."},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.antiviral.2017.01.024_bib22","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/514263","article-title":"Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62","volume":"178","author":"Kinchington","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.01.024_bib23","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1128\/JVI.69.10.6030-6037.1995","article-title":"Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB","volume":"69","author":"Lang","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10048-009-0213-1","article-title":"Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models","volume":"10","author":"Leal","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.antiviral.2017.01.024_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00558-12","article-title":"A\u00a0novel selective LSD1\/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency","volume":"4","author":"Liang","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2017.01.024_bib26","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/JVI.73.4.2825-2831.1999","article-title":"Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells","volume":"73","author":"Lukac","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib27","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1128\/JVI.68.8.5184-5193.1994","article-title":"Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex","volume":"68","author":"Lukac","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib28","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1074\/jbc.273.26.16509","article-title":"Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters","volume":"273","author":"Majello","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.01.024_bib29","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1128\/MCB.14.10.6896","article-title":"The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter","volume":"14","author":"Meier","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib30","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1212\/WNL.45.12_Suppl_8.S30","article-title":"Interactions between varicella-zoster virus IE62 and cellular transcription factor USF in the coordinate activation of genes 28 and 29","volume":"45","author":"Meier","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.antiviral.2017.01.024_bib31","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1128\/JVI.67.12.7573-7581.1993","article-title":"Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters","volume":"67","author":"Meier","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib32","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.03309-14","article-title":"The 6-aminoquinolone WC5 inhibits different functions of the immediate-early 2 ( IE2 ) protein of human cytomegalovirus that are essential for viral replication","volume":"58","author":"Mercorelli","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.01.024_bib33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.68.3.1350-1359.1994","article-title":"Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase","volume":"68","author":"Ng","year":"1994","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib34","first-page":"8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection (retroviral packaing cells\/gene therapy)","volume":"90","author":"Pear","year":"1993","journal-title":"Cell Biol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1074\/jbc.275.1.487","article-title":"The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62","volume":"275","author":"Perera","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.01.024_bib36","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1099\/vir.0.19335-0","article-title":"Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication","volume":"84","author":"Rahaus","year":"2003","journal-title":"J.\u00a0Gen. Virol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.antiviral.2017.01.024_bib37","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1002\/jmv.10328","article-title":"Cellular factors and IE62 activation of VZV promoters","volume":"70","author":"Ruyechan","year":"2003","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib38","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/JVI.69.10.5959-5968.1995","article-title":"The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture","volume":"69","author":"Schmolke","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib39","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1073\/pnas.84.20.7213","article-title":"Insertion and deletion mutagenesis of the human cytomegalovirus genome","volume":"84","author":"Spaete","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.01.024_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000150507","article-title":"Activation and regulation of human cytomegalovirus early genes","volume":"39","author":"Spector","year":"1996","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2017.01.024_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0078242","article-title":"Temporal association of herpes simplex virus ICP4 with cellular complexes functioning at multiple steps in PolII transcription","volume":"8","author":"Wagner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.01.024_bib42","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/AAC.00342-06","article-title":"Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies","volume":"50","author":"Wang","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.01.024_bib43","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/JVI.78.4.1817-1830.2004","article-title":"Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression","volume":"78","author":"White","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib44","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI73805","article-title":"CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses","volume":"124","author":"Yamamoto","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2017.01.024_bib45","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1128\/JVI.00054-09","article-title":"Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex","volume":"83","author":"Yamamoto","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib46","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1128\/JVI.00309-06","article-title":"Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF","volume":"80","author":"Yang","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib47","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1128\/JVI.70.10.7062-7070.1996","article-title":"The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site","volume":"70","author":"Yoo","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.01.024_bib48","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1073\/pnas.1635160100","article-title":"Functional map of human cytomegalovirus AD169 defined by global mutational analysis","volume":"100","author":"Yu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.01.024_bib49","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jmv.24286","article-title":"The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication","volume":"87","author":"Zhang","year":"2015","journal-title":"J.\u00a0Med. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T16:48:27Z","timestamp":1601570907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216305411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"alternative-id":["S0166354216305411"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.024","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}